ワクチン用ガラスバイアルの世界市場-2022-2029

市場力学

新たな疾病の発生が増加

ワクチン用ガラスバイアルは、病気の発生を防ぐために作られたワクチンの保管や輸送に使用されます。過去数十年間、新たな疾病が社会に導入され、疫病が増加するのを示してきました。例えばWHOは2021年5月にエボラ出血熱の発生を宣言しました。2021年2月7日、コンゴ民主共和国（DRC）の保健省（MOH）は、北キヴ州ビエナ保健地区でエボラウイルス病（EVD）患者が確認されたと発表しました。これらの疾病に対抗するためには、リスクにさらされた人々への大規模なワクチン接種が必要であり、予測期間中にワクチン用ガラスバイアルへの需要を急増させます。同時に、これまでの2021-22年シーズンのインフルエンザについて、CDCは、米国におけるインフルエンザによる死亡者数は1,700人、インフルエンザ患者数は290万人、入院者数は2万8,000人と推定しています。これらの疾患の高い流行と再発は、ワクチンの保管と輸送を支援するワクチン用ガラスバイアルの需要をかき立て、市場の成長を後押ししています。

一方、規制機関は、ガラス製包装を使用する患者にとって可能な限り安全であることを保証するために、無菌充填/終了操作の汚染リスクを管理しています。このため、ガラスバイアルの生産とその充填手順は、政府の安全プロトコルに対して厳格なものとなり、市場の成長を阻害しています。

世界のワクチン用ガラスバイアル市場レポートでは、約51の市場データ表、43の図と190ページへのアクセスを提供するであろう

目次

第1章 調査手法と範囲

• 調査手法
• 市場の範囲

第2章 主な動向と発展

第3章 エグゼクティブサマリー

• 製品タイプ別市場内訳
• アプリケーション別市場内訳
• 地域別市場内訳

第4章 市場力学

• 市場影響要因
  • 促進要因
  • 抑制要因
  • ビジネスチャンス
• 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• PEST分析
• プライシング分析
• リインバースメント分析
• 法規制分析
• アンメットニーズ
• 特許動向

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、あるいは将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み

第7章 製品タイプ別

• 成形ガラス製バイアル
• チューブラーガラスバイアル

第8章 用途別

• 予防ワクチン
• 治療用ワクチン

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第10章 競合情勢

• 競合シナリオ
• 競合他社の戦略分析
• 市況/シェア分析
• M&A（合併・買収）分析

第11章 企業プロファイル

• Schott AG
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Origin Ltd
• DWK Life Sciences.
• Nippon Electric Glass.
• Pacific Vial Manufacturing.
• SGD Pharma.
• CORNING
• NIPRO
• RICHLAND GLASS
• Stevanato Group
• FOUR STARS GLASS

第12章 DataM

Market Overview

Glass vaccine vial market was valued at USD 552.28 million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 10.78% during the forecast period (2022-2029).

A glass vaccine vial is a small glass vessel or bottle used to store medication as liquids, especially vaccines. For sterilization, glass provides greater thermal stability, increased clarity, exceptional impermeability, excellent barrier properties, chemical tolerance, enhanced regulatory approval, and lower environmental effects. A glass vaccine vial may be made either by injecting molten glass into a mold or by sectioning and finishing the tubular glass. The major factors propelling the growth of the glass vaccine vial market are growing incidences of infectious diseases spreading across the globe, such as HIV, Ebola, Hepatitis, and more. The need to protect the population from these spreading viruses creates a higher demand for vaccination served in these vials. Further, the increasing vaccine trials and development worldwide for tackling the spread of diseases drives the demand for glass vaccine vials as vaccine trials start from a limited patient base to trial on mass population. This mass trial requires a higher number of vials for vaccine transport. Moreover, the glass material used for vials is advantageous over other materials due to thermal stability, transparency, sterilization, and more, which positively impacts the inclination towards glass vaccine vials

Market Dynamics: Increasing prevalence of new disease outbreaks

Glass vaccine vial is used to store and transport vaccines made for combating the outbreaks of diseases. The previous decades have witnessed an increase in epidemics with new diseases being introduced into society. For instance: WHO declared Ebola outbreak in May 2021. On February 7, 2021 the Ministry of Health (MOH) in the Democratic Republic of the Congo (DRC) announced that a case of Ebola virus disease (EVD) had been confirmed in Biena Health Zone, North Kivu Province. To combat these diseases, large-scale vaccination of the risk-associated population is required, which surges the demand for glass vaccine vials during the forecast period. Simultaneously, for the 2021-22 flu season so far, the CDC estimated there have been 1,700 flu deaths, 2.9 million flu cases, and 28,000 hospitalizations because of the flu in the United States. The high prevalence and reoccurrence of these diseases stir the demand for glass vaccine vails to aid in the storage and transport of vaccines, driving the market growth.

On the other hand, the regulatory bodies control the contamination risk of aseptic fill/finish operations to ensure that glass packaging is as safe as possible for the patients using it. This makes the production of glass vials and their filling procedures rigid towards government safety protocols which hinder the market growth.

Market Segmentation: Molded Glass Vial segment is projected to be the dominant segment in the market during the forecast period.

Molded glass vial dominated the global market in 2021, as the molded glass vials offer higher design flexibility which provides the vial high mechanical resistance reducing the risk of breakage. Therefore, molded glass vial's increasing usage in the glass vaccine vial product types is expected to propel segmental growth shortly.

Based on application, preventive vaccines held the dominant position in the global market during the forecast period. The sudden outbreak of diseases with concentrated risk zones propels the population to take precautions against being infected by the disease, supporting the segment growth during the forecast period. Moreover, the preventive vaccine is also expected to project a considerable CAGR during the forecast period.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period

Asia-Pacific was held a dominant position in the global glass vaccine vial market in 2021. In Asia-Pacific, China is expected to represent considerable growth during the forecast period. As in the Region, the presence of major market players propels the market growth. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. Well established healthcare infrastructure, along with the rise in vaccine developments, is expected to propel the market growth across the region. Glass vaccine vial market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the population and increasing patient pool, especially in India and China.

Competitive Landscape:

The glass vaccine vial market is highly competitive, owing to the presence of big food brands. The key glass vaccine vial players contributing to the growth of the global market include Schott AG, Origin Ltd, DWK Life Sciences, Nippon Electric Glass, Pacific Vial Manufacturing, Corning, SGD Pharma, Nipro, Richland Glass, Stevanato Group, Four Stars Glass, among others. The major players are adopting new product type launch and expansion strategies for global growth in the glass vaccine vial market. In November 2021, Corning opened a new pharmaceutical vial manufacturing factory in Durham, North Carolina, where it said it can produce 500 million glass vials per year to improve the domestic supply chain and deliver Covid-19 vaccines and other drugs to the U.S. and abroad.

COVID-19 Impact: Positive impact on the global glass vaccine vial market

The outbreak of COVID-19 has positively impacted the growth of the Glass Vaccine Vial market globally. The escalated cases of COVID-19 across the globe, along with the high number of vaccine trials and development coupled with COVID-19 vaccination drives, have triggered tremendous demand for glass vaccine vials. Therefore, the COVID-19 pandemic boosted the market value of the glass vaccine vial market in 2021.

The global glass vaccine vial market report would provide an access to approximately 51 market data tables, 43 figures and 190 pages

Table of Contents

Scope and Methodology

• 1.1. Research Methodology
• 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

• 3.1. Market Snippet by Product Type
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by Region

4. Market Dynamics

• 4.1. Market impacting factors
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
• 4.2. Impact analysis

5. Industry Analysis

• 5.1. Porter's five forces analysis
• 5.2. Supply Chain analysis
• 5.3. PEST Analysis
• 5.4. Pricing Analysis
• 5.5. Reimbursement Analysis
• 5.6. Regulatory Analysis
• 5.7. Unmet Needs
• 5.8. Patent Trends

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Type Segment
  • 7.1.2. Market attractiveness index, By Product Type Segment
• 7.2. Molded Glass Vial*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
• 7.3. Tubular Glass Vial

8. By Application

• 8.1. Introduction
  • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
  • 8.1.2. Market attractiveness index, By Application Segment
• 8.2. Preventive Vaccine *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
• 8.3. Therapeutic Vaccine

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key region-specific dynamics
  • 9.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Rest of South America
• 9.4. Europe
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 9.4.5.1. Germany
    • 9.4.5.2. U.K.
    • 9.4.5.3. France
    • 9.4.5.4. Spain
    • 9.4.5.5. Italy
    • 9.4.5.6. Rest of Europe
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application

10. Competitive Landscape

• 10.1. Competitive scenario
• 10.2. Competitor strategy analysis
• 10.3. Market positioning/share analysis
• 10.4. Mergers and acquisitions analysis

11. Company Profiles

• 11.1. Schott AG*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Origin Ltd
• 11.3. DWK Life Sciences.
• 11.4. Nippon Electric Glass.
• 11.5. Pacific Vial Manufacturing.
• 11.6. SGD Pharma.
• 11.7. CORNING
• 11.8. NIPRO
• 11.9. RICHLAND GLASS
• 11.10. Stevanato Group
• 11.11. FOUR STARS GLASS
• List not Exhaustive*

12. DataM

• 12.1. Appendix
• 12.2. About us and services
• 12.3. Contact us